The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Hot topics in necrotising skin and soft tissue infections
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other virulence factors, such as α-hemolysin and phenol-soluble modulins, likely synergize with PVL to drive necrotizing phenotypes [113,114].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [113]
In the citing paper
“Furthermore, other toxins (e.g., α-hemolysin, phenol-soluble modulins) can replicate PVL’s necrotizing effects, suggesting functional redundancy in S. aureus pathogenesis [109,113].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [113]
In the citing paper
“PVL also activates nuclear factor-kappa B (NF-κB) in neutrophils, exacerbating cytokine storms and systemic inflammation, as observed in necrotizing pneumonia and acute respiratory distress syndrome (ARDS) [104,105,113].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011
Neblett Fanfair, R., Benedict, K., Bos, J., Bennett, S. D., Lo, Y.-C., Adebanjo, T., Etienne, K., Deak, E., Derado, G., Shieh, W.-J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204781 · Cited by 360
Risk Factors for Skin and Soft‐Tissue Abscesses among Injection Drug Users: A Case‐Control Study
Murphy, E. L., DeVita, D., Liu, H., Vittinghoff, E., Leung, P., Ciccarone, D. H., & Edlin, B. R. (2001) · Clinical Infectious Diseases · doi:10.1086/320879 · Cited by 262
Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis.
Chao, W.-N., Tsai, C.-F., Chang, H.-R., Chan, K.-S., Su, C.-H., Lee, Y.-T., Ueng, K.-C., Chen, C.-C., Chen, S.-C., & Lee, M.-C. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2012.08.008 · Cited by 117
Binswanger, I. A., Takahashi, T. A., Bradley, K., Dellit, T. H., Benton, K. L., & Merrill, J. O. (2008) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2008.69.924 · Cited by 66
Research works printed but not linked: 89
- Esposito, 2017, Italian Society of Infectious and Tropical Diseases. Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update, J Chemother, 29, 197, 10.1080/1120009X.2017.1311398 · DOI
- Misiakos, 2017, Early diagnosis and surgical treatment for necrotizing fasciitis: a multicenter study, Front Surg, 4, 5, 10.3389/fsurg.2017.00005 · DOI
- Chen, 2017, Presentation and outcomes of necrotizing soft tissue infections, Int J Gen Med, 10, 215, 10.2147/IJGM.S131768 · DOI
- Dryden, 2010, Complicated skin and soft tissue infection, J Antimicrob Chemother, 65
- Esposito, 2011, J Chemother, 23, 251, 10.1179/joc.2011.23.5.251 · DOI
- Wong, 2004, The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections, Crit Care Med, 32, 1535, 10.1097/01.CCM.0000129486.35458.7D · DOI · Paper page
- Chao, 2012, The Laboratory Risk Indicator for Necrotizing Fasciitis score for discernment of necrotizing fasciitis originated from Vibrio vulnificus infections, J Trauma Acute Care Surg, 73, 1576, 10.1097/TA.0b013e318270d761 · DOI
- Thomas, 2012, Retrospective evaluation of laboratory-based diagnostic tools for cervical necrotizing fasciitis, Laryngoscope, 122, 2683, 10.1002/lary.23680 · doi:10.1002/lary.23680
- El-Menyar, 2017, The laboratory risk indicator for necrotizing fasciitis (LRINEC) scoring: the diagnostic and potential prognostic role, Scand J Trauma Resusc Emerg Med, 25, 28, 10.1186/s13049-017-0359-z · DOI
- Neeki, 2017, Evaluating the laboratory risk indicator to differentiate cellulitis from necrotizing fasciitis in the emergency department, West J Emerg Med, 18, 684, 10.5811/westjem.2017.3.33607 · doi:10.5811/westjem.2017.3.33607
- Sanchez-Porto, 2010, Necrotizing soft-tissue infections in a general hospital, Infez Med, 18, 191
- Esposito, 2016, Hot topics in the diagnosis and management of skin and soft-tissue infections, Int J Antimicrob Agents, 48, 19, 10.1016/j.ijantimicag.2016.04.011 · DOI
- Chan, 2008, Low sensitivity of physical examination findings in necrotizing soft tissue infection is improved with laboratory values: a prospective study, Am J Surg, 196, 926, 10.1016/j.amjsurg.2008.07.025 · DOI
- Hadeed, 2016, Early surgical intervention and its impact on patients presenting with necrotizing soft tissue infections: A single academic center experience, J Emerg Trauma Shock, 9, 22, 10.4103/0974-2700.173868 · DOI
- Devaney, 2015, Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality, Anaesth Intensive Care, 43, 685, 10.1177/0310057X1504300604 · DOI
- Marinis, 2013, Vacuum-assisted therapy accelerates wound healing in necrotizing soft tissue infections: our experience in two intravenous drug abuse patients, Infez Med, 21, 305
- Dryden, 2017, Reactive oxygen therapy: a novel therapy in soft tissue infection, Curr Opin Infect Dis, 30, 143, 10.1097/QCO.0000000000000350 · doi:10.1097/qco.0000000000000350
- Lamagni, 2008, Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004, Emerg Infect Dis, 14, 202, 10.3201/eid1402.070888 · DOI
- Turner, 2013, Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes, J Clin Microbiol, 51, 2089, 10.1128/JCM.00679-13 · DOI
- Nizet, 2007, Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets, J Allergy Clin Immunol, 120, 13, 10.1016/j.jaci.2007.06.005 · DOI · Paper page
- Steer, 2012, Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK, J Infect, 64, 1, 10.1016/j.jinf.2011.11.001 · doi:10.1016/j.jinf.2011.11.001
- Sultan, 2012, Necrotising fasciitis, BMJ, 345, e4274, 10.1136/bmj.e4274 · doi:10.1136/bmj.e4274
- Chen, 2011, The microbiological profile and presence of bloodstream infection influence mortality rates in necrotizing fasciitis, Crit Care, 15, R152, 10.1186/cc10278 · DOI
- Lee, 2008, Necrotizing fasciitis in patients with liver cirrhosis: predominance of monomicrobial Gram-negative bacillary infections, Diagn Microbiol Infect Dis, 62, 219, 10.1016/j.diagmicrobio.2008.05.016 · DOI
- Kuo, 2007, Necrotizing fasciitis caused by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention, Eur J Clin Microbiol Infect Dis, 26, 785, 10.1007/s10096-007-0358-5 · DOI
- Lee, 2014, Prognostic factor of mortality and its clinical implications in patients with necrotizing fasciitis caused by Vibrio vulnificus, Eur J Clin Microbiol Infect Dis, 33, 1011, 10.1007/s10096-013-2039-x · DOI
- Tsai, 2011, Comparison of necrotizing fasciitis and sepsis caused by Vibrio vulnificus and Staphylococcus aureus, J Bone Joint Surg Am, 93, 274, 10.2106/JBJS.I.01679 · DOI
- Tsai, 2010, Laboratory indicators for early detection and surgical treatment of vibrio necrotizing fasciitis, Clin Orthop Relat Res, 468, 2230, 10.1007/s11999-010-1311-y · DOI
- Chen, 2012, Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period, J Antimicrob Chemother, 67, 488, 10.1093/jac/dkr476 · DOI
- Hong, 2014, Temporizing surgical management improves outcome in patients with Vibrio necrotizing fasciitis complicated with septic shock on admission, Burns, 40, 446, 10.1016/j.burns.2013.08.012 · DOI
- Shaked, 2012, Unusual "flesh-eating" strains of Escherichia coli, J Clin Microbiol, 50, 4008, 10.1128/JCM.02316-12 · doi:10.1128/jcm.02316-12
- Kelesidis, 2009, Postirradiation Klebsiella pneumoniae-associated necrotizing fasciitis in the western hemisphere: a rare but life-threatening clinical entity, Am J Med Sci, 338, 217, 10.1097/MAJ.0b013e3181a393a4 · DOI
- Reisman, 2012, Monomicrobial Pseudomonas necrotizing fasciitis: a case of infection by two strains and a review of 37 cases in the literature, Scand J Infect Dis, 44, 216, 10.3109/00365548.2011.626441 · DOI
- Khawcharoenporn, 2006, Salmonella group C necrotizing fasciitis: a case report and review of the literature, Diagn Microbiol Infect Dis, 54, 319, 10.1016/j.diagmicrobio.2005.10.015 · DOI
- Spadaro, 2014, Aeromonas sobria necrotizing fasciitis and sepsis in an immunocompromised patient: a case report and review of the literature, J Med Case Rep, 22, 315, 10.1186/1752-1947-8-315 · doi:10.1186/1752-1947-8-315
- Tena, 2010, Fulminant necrotizing fasciitis due to Vibrio parahaemolyticus, J Med Microbiol, 59, 235, 10.1099/jmm.0.014654-0 · doi:10.1099/jmm.0.014654-0
- Gillet, 2011, Pragmatic management of Panton–Valentine leukocidin-associated staphylococcal diseases, Int J Antimicrobial Agents, 38, 457, 10.1016/j.ijantimicag.2011.05.003 · DOI
- Rose, 2015, Cytotoxic virulence predicts mortality in nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus, J Infect Dis, 211, 1862, 10.1093/infdis/jiu554 · DOI
- Bubeck Wardenburg, 2008, Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease, J Infect Dis, 198, 1166, 10.1086/592053 · DOI · Paper page
- Stevens, 2014, Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America, Clin Infect Dis, 59, 147, 10.1093/cid/ciu444 · DOI · Paper page
- Le VT, 2017, Effects of tedizolid phosphate on survival outcomes and suppression of production of staphylococcal toxins in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia, Antimicrob Agents Chemother, 61
- Saeed, 2018, Panton-Valentine Leucocidin-positive Staphylococcus aureus a position statement from the International Society of Chemotherapy, IJAA, 51, 16
- Brindle, 2017, Adjunctive clindamycin for cellulitis: a clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis, BMJ Open, 7, 10.1136/bmjopen-2016-013260 · doi:10.1136/bmjopen-2016-013260
- Petrikkos, 2012, Epidemiology and clinical manifestations of mucormycosis, Clin Infect Dis, 54, S23, 10.1093/cid/cir866 · DOI · Paper page
- Vitrat-Hincky, 2009, Severe filamentous fungal infections after widespread tissue damage due to traumatic injury: six cases and review of the literature, Scand J Infect Dis, 41, 491, 10.1080/00365540902856537 · DOI
- Jain, 2006, Zygomycotic necrotizing fasciitis in immunocompetent patients: a series of 18 cases, Mod Pathol, 19, 1221, 10.1038/modpathol.3800639 · DOI
- Ho, 2015, Necrotizing fasciitis caused by Cryptococcus gattii, Am J Orthop, 44, E517
- Prasanna Kumar, 2014, Fungal necrotizing fasciitis in 3 patients with uncontrolled diabetes, Ear Nose Throat J, 93, E18
- Chander, 2015, Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales), Rev Iberoam Micol, 32, 93, 10.1016/j.riam.2014.06.005 · DOI
- Neblett Fanfair, 2012, Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011, N Engl J Med, 367, 2214, 10.1056/NEJMoa1204781 · DOI · Paper page
- Kordy, 2004, Successful treatment of a child with posttraumatic necrotizing fasciitis caused by Apophysomyces elegans: case report and review of literature, Pediatr Infect Dis J, 23, 877, 10.1097/01.inf.0000136870.17071.fd · DOI
- Ruiz, 2004, Necrotizing fasciitis in an immunocompetent patient caused by Apophysomyces elegans, Biomedica, 24, 239, 10.7705/biomedica.v24i3.1270 · doi:10.7705/biomedica.v24i3.1270
- Spellberg B, Ibrahim A, Roilides E, Lewis R, Lortholary O, Petrikkos G, et al. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis 2012;54(Suppl 1):S73–8. · DOI · Paper page
- Martinelli, 1998, Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation, Bone Marrow Transplant, 22, 1023, 10.1038/sj.bmt.1701438 · doi:10.1038/sj.bmt.1701438
- Mills, 2010, Outcomes from treatment of necrotizing soft-tissue infections: results from the National Surgical Quality Improvement Program database, Am J Surg, 200, 790, 10.1016/j.amjsurg.2010.06.008 · DOI
- Keung, 2013, Immunocompromised status in patients with necrotizing soft-tissue infection, JAMA Surg, 148, 419, 10.1001/jamasurg.2013.173 · doi:10.1001/jamasurg.2013.173
- Vaiman, 2015, Ecthyma gangrenosum and ecthyma-like lesions: review article, Eur J Clin Microbiol Infect Dis, 34, 633, 10.1007/s10096-014-2277-6 · doi:10.1007/s10096-014-2277-6
- Nakanishi, 2016, Mimicker of necrotising fasciitis with systemic inflammatory response syndrome: recurrent necrotising Sweet's syndrome associated with chronic myelogenous leukaemia, BMJ Case Rep, 10.1136/bcr-2016-214461 · doi:10.1136/bcr-2016-214461
- Crane, 1986, Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy, Rev Infect Dis, 8, 364, 10.1093/clinids/8.3.364 · DOI
- Dahlman, 2015, Correlates of skin and soft tissue infections in injection drug users in a syringe-exchange program in Malmo, Sweden, Subst Use Misuse, 50, 1529, 10.3109/10826084.2015.1023450 · DOI
- Ebright, 2002, Skin and soft tissue infections in injection drug users, Infect Dis Clin North Am, 16, 697, 10.1016/S0891-5520(02)00017-X · DOI · Paper page
- Dancer, 2002, Bacillus cereus cellulitis from contaminated heroin, J Med Microbiol, 51, 278, 10.1099/0022-1317-51-3-278 · DOI
- Dunbar, 2007, Necrotizing fasciitis: manifestations, microbiology and connection with black tar heroin, J Forensic Sci, 52, 920, 10.1111/j.1556-4029.2007.00452.x · DOI
- Passaro, 1998, Wound botulism associated with black tar heroin among injecting drug users, JAMA, 279, 859, 10.1001/jama.279.11.859 · DOI · Paper page
- Pascual, 2003, Tetanus surveillance – United States, 1998–2000, MMWR Surveill Summ, 52, 1
- Totapally, 2017, Epidemiology and outcomes of hospitalized children with necrotizing soft-tissue infections, Pediatr Infect Dis J, 36, 641, 10.1097/INF.0000000000001498 · doi:10.1097/inf.0000000000001498
- Endorf, 2012, Characteristics, therapies, and outcome of children with necrotizing soft tissue infections, Pediatr Infect Dis J, 31, 221, 10.1097/INF.0b013e3182456f02 · DOI
- Zundel, 2017, Diagnosis and treatment of pediatric necrotizing fasciitis: a systematic review of the literature, Eur J Pediatr Surg, 27, 127
- Crum, 2004, Bacterial pyomyositis in the United States, Am J Med, 117, 420, 10.1016/j.amjmed.2004.03.031 · doi:10.1016/j.amjmed.2004.03.031
- Small, 2005, Tropical and temperate pyomyositis, Infect Dis Clin North Am, 19, 981, 10.1016/j.idc.2005.08.003 · doi:10.1016/j.idc.2005.08.003
- Comegna, 2016, Pyomyositis is not only a tropical pathology: a case series, J Med Case Rep, 10, 372, 10.1186/s13256-016-1158-2 · doi:10.1186/s13256-016-1158-2
- Sissolak, 1994, Tropical pyomyositis, J Infect, 29, 121, 10.1016/S0163-4453(94)90530-4 · doi:10.1016/s0163-4453(94)90530-4
- Rayes, 2000, Tropical pyomyositis and human toxocariasis: a clinical and experimental study, Am J Med, 109, 422, 10.1016/S0002-9343(00)00512-X · DOI
- Struk, 2001, Imaging of soft tissue infections, Radiol Clin North Am, 39, 277, 10.1016/S0033-8389(05)70278-5 · DOI · Paper page
- Theodorou, 2007, MR imaging findings of pyogenic bacterial myositis (pyomyositis) in patients with local muscle trauma: illustrative cases, Emerg Radiol, 14, 89, 10.1007/s10140-007-0593-1 · doi:10.1007/s10140-007-0593-1
- Stevens, 1987, Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens, J Infect Dis, 155, 220, 10.1093/infdis/155.2.220 · DOI
- Takazawa, 2015, Clinical features of non-clostridial gas gangrene and risk factors for in-hospital mortality, Tokai J Exp Clin Med, 40, 124
- Stevens, 2005, Practice guidelines for the diagnosis and management of skin and soft-tissue infections, Clin Infect Dis, 41, 1373, 10.1086/497143 · DOI · Paper page
- Takei, 1993, Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens, J Clin Investig, 91, 602, 10.1172/JCI116240 · DOI · Paper page
- Norrby-Teglund, 1996, Plasma from patients with severe invasive Group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production, J Immunol, 156, 3057, 10.4049/jimmunol.156.8.3057 · DOI · Paper page
- Basma, 1998, Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections, Infect Immun, 66, 2279, 10.1128/IAI.66.5.2279-2283.1998 · doi:10.1128/iai.66.5.2279-2283.1998
- Sriskandan, 2006, Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation, J Antimicrob Chemother, 58, 117, 10.1093/jac/dkl173 · DOI
- Koch, 2015, Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature, Ann Med Surg, 4, 260, 10.1016/j.amsu.2015.07.017 · doi:10.1016/j.amsu.2015.07.017
- Raithatha, 2012, Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease, Indian J Crit Care Med, 16, 37, 10.4103/0972-5229.94433 · doi:10.4103/0972-5229.94433
- Cawley, 1999, Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review, Pharmacotherapy, 19, 1094, 10.1592/phco.19.13.1094.31589 · DOI
- Darenberg, 2003, Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomised, double-blind, placebo-controlled trial, Clin Infect Dis, 37, 333, 10.1086/376630 · DOI · Paper page
- Kaul, 1999, Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—a comparative observational study, The Canadian Streptococcal Study Group. Clin Infect Dis, 28, 800, 10.1086/515199 · DOI · Paper page
- Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study Clin Infect Dis 2014 ; 59 : 851–7. · DOI · Paper page
- Shah, 2009, Intravenous immunoglobulin in children with streptococcal toxic shock syndrome, Clin Infect Dis, 49, 1369, 10.1086/606048 · DOI
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Anti-bacterial monoclonal antibodies: Next generation therapy against superbugs
Wang, H., Chen, D., & Lu, H. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11989-w · Cited by 45
Metadata
- Authors
- Saeed, K., Esposito, S., Gould, I., Ascione, T., Bassetti, M., Bonnet, E., Bouza, E., Chan, M., Davis, J. S., De Simone, G., Dryden, M., Gottlieb, T., Hijazi, K., Lye, D. C., Pagliano, P., Petridou, C., Righi, E., Segreti, J., Unal, S., & Yalcin, A. N.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 52
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0924-8579
- Cited by
- 35
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hot topics in necrotising skin and soft tissue infections. https://app.cochat.ai/papers/10.1016/j.ijantimicag.2018.02.012
- The paper
- Saeed, K., Esposito, S., Gould, I., Ascione, T., Bassetti, M., Bonnet, E., Bouza, E., Chan, M., Davis, J. S., De Simone, G., Dryden, M., Gottlieb, T., Hijazi, K., Lye, D. C., Pagliano, P., Petridou, C., Righi, E., Segreti, J., Unal, S., & Yalcin, A. N. (2018). Hot topics in necrotising skin and soft tissue infections. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2018.02.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.